FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

The move by the Trump administration is a major reprieve for big tech companies, and has wide-ranging implications for the U.S. economy. Scott Bessent Takes Tricky Center Stage as Trade Wars Roil ...